Submitted:
03 September 2026
Posted:
07 September 2026
You are already at the latest version
Abstract
Isoquinoline alkaloids such as sanguinarine and chelerythrine have demonstrated antimicrobial activity against a range of microorganisms; however, their effects on Leptospira spp. remain poorly characterized. In this study, we evaluated the in vitro susceptibility of multiple Leptospira strains to sanguinarine chloride, chelerythrine chloride, and a combined sanguinarine–chelerythrine fraction. Bacterial responses were assessed using flow cytometry, metabolic activity assays, and optical density measurements. The tested com-pounds exhibited limited and strain-dependent effects. The most pronounced response was observed in Leptospira interrogans serovar Australis (strain Balico), where chelerythrine chloride consistently reduced viability and metabolic activity under the conditions tested. In contrast, other strains showed minimal or inconsistent responses. The combined fraction did not demonstrate enhanced activity compared to individual compounds. These findings indicate that isoquinoline alkaloids exert variable and generally modest effects on Leptospira spp., highlighting substantial inter-strain heterogeneity in susceptibility. While the observed activity is limited, this work provides a preliminary assessment of these compounds in Leptospira and underscores the need for further studies to clarify their mechanisms of action and potential relevance.
Keywords:
1. Introduction
2. Results
2.1. Effects of Isoquinoline Alkaloids on Leptospira Growth and Viability
2.1. Metabolic Activity (Alamar Blue Assay)
3. Discussion
Effects of Sanguinarine Chloride
Effect of Chelerythrine Chloride
Effects of the Sanguinarine-Chelerythrine Fraction
Strain-Dependent Responses of Leptospira
Implications and Limitations
4. Materials and Methods
4.1. Bacterial Strains and Culture Conditions
4.2. Compounds and Treatment Conditions
4.3. Assessment of Metabolic Activity Using Alamar Blue Assay
4.4. Flow Cytometry Analysis and Viability Assessment
4.5. Cell Enumeration
4.6. Optical Density Measurements
4.7. Dark-Field Microscopy
4.8. Statistical Analysis
5. Conclusions
Author Contributions
Funding
Data Availability Statement
Conflicts of Interest
References
- Álvarez-Martínez, F.J.; Barrajón-Catalán, E.; Herranz-López, M.; Micol V. Antibacterial plant compounds, extracts and essential oils: An updated review on their effects and putative mechanisms of action. Phytomedicine 2021, 90, 153626.
- Jubair, N.; Rajagopal, M.; Chinnappan, S.; Abdullah N.B.; Fatima A. Review on the antibacterial mechanism of plant-derived compounds against multidrug-resistant bacteria (MDR). BioMed Research International 2021 3663315.
- Angelini, P. Plant-derived antimicrobials and their crucial role in combating antimicrobial resistance. Antibiotics 2024, 13: 746.
- Woo, S.; Marquez, L.; Crandall, W.; Risener, C.; Quave, C.L. Recent advances in the discovery of plant-derived antimicrobial natural products to combat antimicrobial resistant pathogens: insights from 2018–2022. Natural Product Reports 2023, 40, 1271–1290.
- Wójciak, M.; Feldo, M.; Stolarczyk, P.; Płachno, B.J. Carnivorous Plants from Nepenthaceae and Droseraceae as a Source of Secondary Metabolites. Molecules 2023, 28, 2155. [CrossRef]
- Wójciak, M., Feldo, M., Stolarczyk, P., Płachno, B. J. Biological potential of carnivorous plants from Nepenthales. Molecules 2023 a, 28(8), 3639.
- Miclea, I. Secondary Metabolites with Biomedical Applications from Plants of the Sarraceniaceae Family. Int. J. Mol. Sci. 2022, 23, 9877.
- Bussabong, P.; Rairat, T.; Chuchird, N.; Keetanon, A.; Phansawat, P.; Cherdkeattipol, K.; Pichitkul, P.; Kraitavin, W. Effects of isoquinoline alkaloids from Macleaya cordata on growth performance, survival, immune response, and resistance to Vibrio parahaemolyticus infection of Pacific white shrimp (Litopenaeus vannamei). PLoS One 2021; [CrossRef]
- Jursky, F.; Baliova, M.; Mihalikova, A. Molecular basis for differential glycine transporters sensitivity to sanguinarine. Toxicology Letters 2012, 212, 3, 262-267.
- Zielińska, S.; Jezierska-Domaradzka, A.; Wójciak-Kosior, M.; Sowa, I.; Junka, A.; Matkowski, A.M. Greater Celandine’s ups and downs−21 centuries of medicinal uses of Chelidonium majus from the viewpoint of today’s pharmacology. Front. Pharmacol. 2018, 9, 299.
- Leyva-Peralta, M.A.; Robles-Zepeda, R. E.; Garibay-Escobar, A.; Ruiz-Bustos, Eduardo.; Alvarez-Berber, L.P.; Gálvez-Ruiz, J.C. In vitro anti-proliferative activity of Argemone gracilenta and identification of some active components. BMC Complementary and Alternative Medicine 2015, 15:13. doi 10.1186/s12906-015-0532-8.
- Kaminskyy, V.; Kulachkovskyy, O.; Stoika, R. Adecisive role of mitochondria in defining rate and intensity of apoptosis induction by different alkaloids. Toxicology Letters 2008, 177, 168–181.
- Zielińska, S.; Wójciak-Kosior, M.; Dziągwa-Becker, M.; Gleńsk, M.; Sowa, I.; Fijałkowski, K.; Rurańska-Smutnicka, D.; Matkowski, A.; Junka, A. The Activity of Isoquinoline Alkaloids and Extracts from Chelidonium majus against Pathogenic Bacteria and Candida sp. Toxins 2019, 11, 406; [CrossRef]
- Zhao, Z.; Shang, X.; Lawoe, R.K.; Liu, Y.; Zhou, R.; Sun, Y.; Yan, Y.; Li, J.; Yang, G.; Yang, C. Anti-phytopathogenic activity and the possible mechanisms of action of isoquinoline alkaloid sanguinarine. Pesticide Biochemistry and Physiology 2019, 159 51–58.
- Adler, B.; de la Peña Moctezuma A. Leptospira and leptospirosis. Vet Microbiol. 2010, 140, 287–296. [CrossRef]
- Picardeau, M. Virulence of the zoonotic agent of leptospirosis: still terra incognita? Nat Rev Microbiol. 2017 a, 15: 297–307. [CrossRef]
- Costa, F.; Hagan, JE.; Calcagno, J.; Kane, M.; Torgerson, P.; Martinez-Silveira, M.S.; Stein, C.; Abela-Ridder, B.; Ko, AI. Global Morbidity and Mortality of Leptospirosis: A Systematic Review. PLoS Negl Trop Dis. 2015 17, 9(9):e0003898. [CrossRef]
- Arent, Z.; Pardyak, L.; Dubniewicz, K.; Płachno, B.; Kotula-Balak, M. Leptospira taxonomy: then and now. Med Weter. 2022, 78: 489–496.
- Lewicka, A.J.; Lyczakowski, J.J.; Pardyak, L.; Dubniewicz, K.; Latowski, D.; Arent Z. Beyond serology: saccharide profiling enables identification of antigenically similar Leptospira and prompts re-evaluation of bacterial lipopolysaccharide evolution. Front Mol Biosci. 2025, 17, 12:1581587. [CrossRef]
- Picardeau, M. Toolbox of Molecular Techniques for Studying Leptospira Spp.. In: Adler, B. (eds) Spirochete Biology: The Post Genomic Era. Current Topics in Microbiology and Immunology 2017b, vol. 415. Springer, Cham. [CrossRef]
- Dubniewicz, K.; Pardyak, L.; Gurgul, A.; Jasielczuk, I.; Szmatoła, T.; Arent, ZJ. Serovar-specific genomic features of Leptospira interrogans Hardjo: implications for host adaptation. Front Mol Biosci. 2025, 12, 1648097. [CrossRef]
- Ahsan, Haseeb.;Reagan-Shaw, Shannon.; Eggert, D.M.; Tan, Thomas C.; Afaq, Farrukh.; Mukhtar, Hasan.; Ahmad, N. Protective Effect of Sanguinarine on Ultraviolet B-mediated Damages in SKH-1 Hairless Mouse Skin: Implications for Prevention of Skin Cancer. Photochemistry and Photobiology 2007, 83: 986–993.
- Yan, S.; Lin, S.; Chen, K.; Yin, S.; Peng, H.; Cai, N.; Ma, W.; Songyang, Z.; Huang, Y. Natural Product Library Screens Identify Sanguinarine Chloride as a Potent Inhibitor of Telomerase Expression and Activity. Cells 2022, 11(9), 1485. [CrossRef]
- Li, J.Y.; Huang, H.; Pan, T.; Wang, N.; Shi, C.; Zhang, Bo.; Wang, C.; Yang G. Sanguinarine induces apoptosis in Eimeria tenella sporozoites via the generation of reactive oxygen species. Poultry Science 2022. 101, 101771, . [CrossRef]
- Jiao, X.; Fu, X.; Li, Q.; Bu, J.; Liu, X.; Savolainen, O.; Huang, L.; Guo, J.; Nielsen, J.; Chen, Y. De novo production of protoberberine and benzophenanthridine alkaloids through metabolic engineering of yeast. Nat Commun 2024, 15, 8759. [CrossRef]
- Huang, L.J.; Lan, J.X.; Wang, J.H.; Huang, H.; Lu, K.; Zhou, Z.N.; Xin, S.Y.; Zhang, Z.Y.; Wang, J.Y.; Dai, P.; Chen, X.M.; Hou, W. Bioactivity and mechanism of action of sanguinarine and its derivatives in the past 10 years. Biomed Pharmacother. 2024, 173, 116406. [CrossRef]
- Petakh, P.; Isevych, V.; Kamyshnyi, A.; Oksenych, V. Weil’s Disease—Immunopathogenesis, Multiple Organ Failure, and Potential Role of Gut Microbiota. Biomolecules 2022, 12, 1830. [CrossRef]
- Chen, N.; Qi, Y.; Ma, X.; Xiao, X.; Liu, Q.; Xia, T.; Xiang, J.; Zeng, J.; Tang, J. Rediscovery of Traditional Plant Medicine: An Underestimated Anticancer Drug of Chelerythrine. Front. Pharmacol., Sec. Ethnopharmacology 2022, 13 - 2022 | . [CrossRef]
- Danielewski, M.; Zielińska, S.; Matuszewska, A.; Słupski, W.; Włodarczyk, M.; Jęśkowiak, I.; Wiatrak, B.; Kowalski, K.; Jezierska-Domaradzka, A.; Ziółkowski, P.; Szeląg, A.; Nowak, B. Sanguinarine-Chelerythrine Fraction of Coptis chinensis Exerts Anti-inflammatory Activity in Carrageenan Paw Oedema Test in Rats and Reveals Reduced Gastrotoxicity. Oxidative Medicine and Cellular Longevity. 2022, 1504929, . [CrossRef]
- Danielewski, M.; Zielińska, S.; Merwid-Ląd, A.; Szandruk-Bender, M.; Słupski, W.; Włodarczyk, M.; Sozański, T.; Ziółkowski, P.; Szeląg, A.; Nowak, B. Sanguinarine–Chelerythrine from Coptis chinensis Offers Analgesic and Anti-Inflammatory Effects Without Gastrotoxicity. Pharmaceutics 2025, 17, 323.
- Dzięgielewska, M.; Zielińska, S.; Dudek, B.; Brożyna, M.; Kozłowska, W.; Matkowski, A.; Bartoszewicz, M.; Yanfang S.; Junka, A. Isoquinoline Alkaloids from Traditional Medicinal Plants of the Papaveraceae as a Third Line of Defense Against Bacterial Ocular Infections, bioRxiv the preprint server for Biology 2025, 11.21.689706; [CrossRef]
- Koizumi, N.; Picardeau, M. Leptospira Spp: Methods and Protocols in Humana 2020, ISBN 1071604600, 9781071604601.
- Heng, W.S.; Cheah, S.-C. Chelerythrine Chloride Downregulates β-Catenin and Inhibits Stem Cell Properties of Non-Small Cell Lung Carcinoma. Molecules 2020, 25, 224. [CrossRef]
- Fontana, C.; Crussard, S.; Simon-Dufay, N.; Pialot, D.; Bomchil, N.; Reyes, J. Use of flow cytometry for rapid and accurate enumeration of live pathogenic Leptospira strains. J.Microbiological Methods 2017, 132, 34-40. [CrossRef]



| Strain | Dose | Incubation (hour) | Total bacteria count (cells/ml) | Live (%) | Dead (%) | OD (420 nm) |
|---|---|---|---|---|---|---|
|
Leptospira interrogans sv. Copenhageni, strain M20 |
Control | 0 | 4.5×107 | 90 | 10 | 0.632 |
|
1 µM |
24 | 4.6×107 | 91 | 9 | 0.688 | |
| 48 | 4.8×107 | 89 | 11 | 0.646 | ||
| 72 | 4.9×107 | 88 | 12 | 0.627 | ||
|
5 µM |
24 | 3.8×107 | 87 | 13 | 0.638 | |
| 48 | 3.7×107 | 88 | 12 | 0.659 | ||
| 72 | 3.4×107 | 86 | 14 | 0.667 | ||
|
10 µM |
24 | 3.9×107 | 81 | 18 | 0.613 | |
| 48 | 4.0×107 | 82 | 17 | 0.612 | ||
| 72 | 3.8×107 | 80 | 20 | 0.620 | ||
|
Leptospira kirschneri sv. Grippotyphosa, strain Moskwa V |
Control | 0 | 2.85×107 | 95 | 5 | 0.598 |
|
1 µM |
24 | 2.7×107 | 92 | 8 | 0.578 | |
| 48 | 2.4×107 | 91 | 9 | 0.601 | ||
| 72 | 2.9×107 | 90 | 10 | 0.597 | ||
|
5 µM |
24 | 1.8×107 | 91 | 9 | 0.599 | |
| 48 | 2.7×107 | 89 | 11 | 0.600 | ||
| 72 | 2.1×107 | 87 | 13 | 0.604 | ||
|
10 µM |
24 | 2.9×107 | 87 | 13 | 0.597 | |
| 48 | 2.2×107 | 85 | 15 | 0.556 | ||
| 72 | 1.8×107 | 84 | 16 | 0.569 | ||
|
Leptospira interrogans sv. Pomona, strain Pomona |
Control | 0 | 3.8×107 | 92 | 8 | 0.650 |
|
1 µM |
24 | 3.4×107 | 90 | 10 | 0.640 | |
| 48 | 2.4×107 | 91 | 9 | 0.630 | ||
| 72 | 2.9×107 | 92 | 8 | 0.635 | ||
|
5 µM |
24 | 3.32×107 | 93 | 7 | 0.601 | |
| 48 | 2.98×107 | 92 | 8 | 0.611 | ||
| 72 | 2.6×107 | 90 | 10 | 0.603 | ||
|
10 µM |
24 | 2.4×107 | 89 | 11 | 0.610 | |
| 48 | 1.98×107 | 88 | 12 | 0.598 | ||
| 72 | 2.01×107 | 87 | 13 | 0.590 | ||
|
Leptospira interrogans sv. Australis, strain Balico |
Control | 0 | 1.5×107 | 89 | 11 | 0.546 |
|
1 µM |
24 | 1.2×107 | 85 | 15 | 0.545 | |
| 48 | 1.15×107 | 84 | 16 | 0.536 | ||
| 72 | 1.7×107 | 82 | 18 | 0.546 | ||
|
5 µM |
24 | 1.3×107 | 83 | 17 | 0.564 | |
| 48 | 1.0×105 | 75 | 25 | 0.460 | ||
| 72 | 0.8×105 | 72 | 18 | 0.401 | ||
|
10 µM |
24 | 1.1×103 | 65 | 35 | 0.312 | |
| 48 | 0.5×103 | 45 | 55 | 0.299 | ||
| 72 | 0.6×102 | 42 | 58 | 0.125 | ||
|
Leptospira borgpetersenii sv. Hardjo, strain KR39 |
Control | 0 | 4.5×107 | 94 | 6 | 0.645 |
|
1 µM |
24 | 4.3×107 | 92 | 8 | 0.630 | |
| 48 | 4.25×107 | 91 | 9 | 0.625 | ||
| 72 | 4.15×107 | 92 | 8 | 0.626 | ||
|
5 µM |
24 | 4.3×107 | 89 | 11 | 0.564 | |
| 48 | 4.0×105 | 85 | 15 | 0.560 | ||
| 72 | 3.8×105 | 82 | 18 | 0.581 | ||
|
10 µM |
24 | 3.4×107 | 86 | 14 | 0.522 | |
| 48 | 3.3×107 | 84 | 16 | 0.569 | ||
| 72 | 3.2×107 | 81 | 19 | 0.545 |
| Strain | Dose | Incubation (hour) | Total bacteria count (cells/ml) | Live (%) | Dead (%) | OD (420 nm) |
|---|---|---|---|---|---|---|
|
Leptospira interrogans sv. Copenhageni strain M20 |
Control | 0 | 4.5×107 | 90 | 10 | 0.632 |
|
1 µM |
24 | 4.6×107 | 91 | 9 | 0.688 | |
| 48 | 4.8×107 | 89 | 11 | 0.646 | ||
| 72 | 4.9×107 | 88 | 12 | 0.627 | ||
|
2 µM |
24 | 3.8×107 | 87 | 13 | 0.638 | |
| 48 | 3.7×107 | 88 | 12 | 0.659 | ||
| 72 | 3.4×107 | 86 | 14 | 0.667 | ||
|
5 µM |
24 | 3.9×107 | 81 | 18 | 0.613 | |
| 48 | 4.0×107 | 82 | 17 | 0.612 | ||
| 72 | 3.8×107 | 80 | 20 | 0.620 | ||
|
Leptospira kirschneri sv. Grippotyphosa strain Moskwa V |
Control | 0 | 4.4×107 | 94 | 6 | 0.65 |
| 1 µM | 24 | 4.2×107 | 93 | 7 | 0.64 | |
| 48 | 4.0×107 | 92 | 8 | 0.63 | ||
| 72 | 2.9×107 | 91 | 9 | 0.635 | ||
| 2 µM | 24 | 3.7×107 | 87 | 13 | 0.601 | |
| 48 | 3.9×107 | 88 | 12 | 0.611 | ||
| 72 | 3.6×107 | 86 | 14 | 0.603 | ||
| 5 µM | 24 | 4.1×107 | 88 | 12 | 0.610 | |
| 48 | 3.9×107 | 82 | 18 | 0.598 | ||
| 72 | 3.6×107 | 80 | 20 | 0.59 | ||
|
Leptospira interrogans sv. Pomona strain Pomona |
Control | 0 | 2.5×107 | 96 | 4 | 0.65 |
| 1 µM | 24 | 2.2×107 | 94 | 6 | 0.64 | |
| 48 | 2.4×107 | 95 | 5 | 0.63 | ||
| 72 | 2.9×107 | 93 | 7 | 0.635 | ||
| 2 µM | 24 | 2.7×107 | 93 | 7 | 0.601 | |
| 48 | 1.9×107 | 92 | 8 | 0.611 | ||
| 72 | 2.6×107 | 96 | 4 | 0.603 | ||
| 5 µM | 24 | 2.7×107 | 92 | 8 | 0.610 | |
| 48 | 1.8×107 | 90 | 10 | 0.67 | ||
| 72 | 2.3×107 | 91 | 9 | 0.65 | ||
|
Leptospira interrogans sv. Australis strain Balico |
Control | 0 | 3.5×107 | 96 | 4 | 0.60 |
| 1 µM | 24 | 3.2×107 | 94 | 6 | 0.61 | |
| 48 | 3.5×107 | 95 | 5 | 0.62 | ||
| 72 | 3.6×107 | 93 | 7 | 0.66 | ||
| 2 µM | 24 | 3.7×107 | 93 | 7 | 0.65 | |
| 48 | 3.5×107 | 92 | 8 | 0.59 | ||
| 72 | 3.6×107 | 96 | 4 | 0.64 | ||
| 5 µM | 24 | 3.4×107 | 93 | 7 | 0.64 | |
| 48 | 3.5×107 | 94 | 6 | 0.61 | ||
| 72 | 3.9×107 | 93 | 7 | 0.59 | ||
|
Leptospira borgpetersenii sv. Hardjo strain KR39 |
Control | 0 | 1.6×107 | 96 | 4 | 0.62 |
| 1 µM | 24 | 1.5×107 | 89 | 11 | 0.61 | |
| 48 | 1.4×107 | 85 | 15 | 0.62 | ||
| 72 | 1.2×107 | 86 | 14 | 0.66 | ||
| 2 µM | 24 | 1.6×106 | 83 | 17 | 0.65 | |
| 48 | 1.5×106 | 82 | 18 | 0.59 | ||
| 72 | 2.6×105 | 80 | 20 | 0.64 | ||
| 5 µM | 24 | 4.4×104 | 75 | 25 | 0.40 | |
| 48 | 2.5×104 | 64 | 36 | 0.31 | ||
| 72 | 3.1×104 | 53 | 47 | 0.36 |
| Strain | Dose | Incubation Time | Total bacteria count (cells/ml) | Live (%) | Dead (%) | OD (420 nm) |
|---|---|---|---|---|---|---|
|
Leptospira interrogans sv. Copenhageni strain M20 |
Control | 0 | 3.4×107 | 89 | 11 | 0.56 |
| 1 µM | 24 | 2.9×107 | 90 | 10 | 0.59 | |
| 48 | 3.0×107 | 91 | 9 | 0.58 | ||
| 72 | 2.9×107 | 90 | 10 | 0.57 | ||
| 2 µM | 24 | 3.1×107 | 85 | 15 | 0.57 | |
| 48 | 3.2×107 | 83 | 17 | 0.59 | ||
| 72 | 3.0×107 | 86 | 14 | 0.58 | ||
| 5 µM | 24 | 3.1×107 | 87 | 13 | 0.56 | |
| 48 | 3.0×107 | 87 | 13 | 0.55 | ||
| 72 | 3.0×107 | 86 | 14 | 0.53 | ||
|
Leptospira kirschneri sv. Grippotyphosa strain Moskwa V |
Control | 0 | 5.4×107 | 90 | 10 | 0.56 |
| 1 µM | 24 | 4.9×107 | 91 | 9 | 0.59 | |
| 48 | 4.6×107 | 89 | 11 | 0.58 | ||
| 72 | 4.7×107 | 86 | 14 | 0.57 | ||
| 2 µM | 24 | 4.0×107 | 86 | 14 | 0.57 | |
| 48 | 4.2×107 | 85 | 15 | 0.59 | ||
| 72 | 4.0×107 | 86 | 14 | 0.58 | ||
| 5 µM | 24 | 4.6×107 | 89 | 11 | 0.57 | |
| 48 | 4.5×107 | 88 | 12 | 0.57 | ||
| 72 | 4.2×107 | 85 | 15 | 0.56 | ||
|
Leptospira interrogans sv. Pomona strain Pomona |
Control | 0 | 2.8×107 | 93 | 7 | 0.58 |
| 1 µM | 24 | 2.6×107 | 92 | 8 | 0.57 | |
| 48 | 2.4×107 | 91 | 9 | 0.58 | ||
| 72 | 2.5×107 | 91 | 9 | 0.56 | ||
| 2 µM | 24 | 2.1×107 | 90 | 10 | 0.54 | |
| 48 | 2.2×107 | 89 | 11 | 0.56 | ||
| 72 | 2.4×107 | 88 | 12 | 0.54 | ||
| 5 µM | 24 | 1.9×107 | 90 | 10 | 0.57 | |
| 48 | 1.8×107 | 89 | 11 | 0.56 | ||
| 72 | 4.5×106 | 87 | 13 | 0.53 | ||
|
Leptospira interrogans sv. Australis strain Balico |
Control | 0 | 1.8×107 | 93 | 7 | 0.60 |
| 1 µM | 24 | 2.5×106 | 92 | 8 | 0.58 | |
| 48 | 1.8×106 | 91 | 9 | 0.57 | ||
| 72 | 1.5×106 | 91 | 9 | 0.56 | ||
| 2 µM | 24 | 1.6×106 | 90 | 10 | 0.57 | |
| 48 | 1.4×106 | 89 | 11 | 0.56 | ||
| 72 | 3.4×105 | 88 | 12 | 0.55 | ||
| 5 µM | 24 | 1.7×105 | 86 | 14 | 0.53 | |
| 48 | 1.8×105 | 82 | 18 | 0.52 | ||
| 72 | 1.5×105 | 79 | 21 | 0.49 | ||
|
Leptospira borgpetersenii sv. Hardjo strain KR39 |
Control | 0 | 3.4×107 | 92 | 8 | 0.61 |
| 1 µM | 24 | 2.9×107 | 91 | 9 | 0.60 | |
| 48 | 2.6×107 | 89 | 11 | 0.59 | ||
| 72 | 2.3×107 | 88 | 12 | 0.58 | ||
| 2 µM | 24 | 3.0×107 | 89 | 11 | 0.59 | |
| 48 | 2.7×107 | 86 | 14 | 0.59 | ||
| 72 | 2.4×107 | 85 | 15 | 0.56 | ||
| 5 µM | 24 | 2.7×107 | 88 | 12 | 0.53 | |
| 48 | 2.5×107 | 87 | 13 | 0.50 | ||
| 72 | 2.0×107 | 86 | 14 | 0.49 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.